Genetic Technologies (GENE)

P/S ratio as of March 2025 (TTM): 0.2168

According to Genetic Technologies's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 3.03. At the end of 2008 the company had a P/S ratio of 1.85.

P/S ratio history for Genetic Technologies from 2005 to 2008

PS ratio at the end of each year

Year	P/S ratio	Change
2008	1.85	-40.58%
2007	3.12	-78.77%
2006	14.7	-12.81%
2005	16.9

P/S ratio for similar companies or competitors

Company	P/S ratio	P/S ratio differencediff.	Country
Eterna Therapeutics ERNA	19.5	8,885.86%	🇺🇸 USA
Myriad Genetics MYGN	0.9675	346.23%	🇺🇸 USA
LabCorp LH	1.48	582.73%	🇺🇸 USA
Quest Diagnostics DGX	1.88	766.97%	🇺🇸 USA
Compugen CGEN	5.19	2,295.74%	🇮🇱 Israel
Danaher DHR	6.17	2,745.66%	🇺🇸 USA
Thermo Fisher Scientific TMO	4.41	1,933.90%	🇺🇸 USA
Neogen NEOG	2.04	842.21%	🇺🇸 USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

P/S ratio for Genetic Technologies (GENE)

P/S ratio as of March 2025 (TTM): 0.2168